Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
527.1 USD | +0.43% | -2.34% | +11.77% |
Apr. 30 | Argus Raises Elevance Health's Price Target to $600 From $540 | MT |
Apr. 30 | GroundGame.Health announced that it has received $17 million in funding from 7wire Ventures, Elevance Health, Inc. | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.81 for the current period. Therefore, the company is undervalued.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Managed Healthcare
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.77% | 122B | A- | ||
-7.44% | 445B | B- | ||
+16.83% | 101B | B- | ||
-1.71% | 38.56B | B- | ||
-31.03% | 37.86B | A- | ||
-6.76% | 19.86B | B- | ||
-14.63% | 3.1B | C+ | ||
-38.79% | 995M | B- | ||
-32.73% | 319M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ELV Stock
- Ratings Elevance Health, Inc.